Income Statement
HCW BIOLOGICS INC.
HCWB
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY |
|---|---|---|---|---|---|
|
Revenue
|
- | - | - | - | - |
|
Cost of Revenue
|
0.04 | 1.61 | 2.28 | 4.14 | - |
|
Gross Profit
|
0.01 | 0.96 | 0.56 | 2.59 | - |
|
Operating Expenses
|
13.17 | 30.98 | 26.28 | 17.67 | 13.37 |
|
Research & Development
|
5.44 | 6.39 | 7.68 | 9.34 | 8.17 |
|
Selling, General & Administrative
|
7.70 | 6.84 | 13.35 | 8.33 | 5.19 |
|
Other Operating Expenses
|
- | - | - | - | - |
|
Operating Income
|
-13.16 | -30.02 | -25.72 | -15.08 | -13.37 |
|
Non-Operating Income
|
0.00 | - | - | - | - |
|
Interest Income
|
- | - | - | - | - |
|
Interest Expense
|
0.85 | 0.63 | 0.28 | 0.13 | - |
|
Other Non-Op Income / Expense
|
- | -1.30 | - | - | - |
|
Income Before Tax
|
-7.96 | -30.02 | -24.99 | -14.90 | -12.86 |
|
Income Tax Expense
|
- | - | - | - | - |
|
Non-Controlling Interest
|
- | - | - | - | - |
|
Net Income
|
-7.96 | -30.02 | -24.99 | -14.90 | -12.86 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY |
|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - |
|
EBITDA
|
-13.16 | -28.84 | -24.58 | -14.36 | -12.82 |
|
Earnings Per Share (Basic)
|
-10.63 | -0.77 | -0.70 | -0.42 | - |
|
Diluted EPS
|
-10.63 | -0.77 | -0.70 | -0.42 | - |
|
Weighted Average Shares
|
2.10 | 38.79 | 35.93 | 35.82 | - |
|
Diluted Weighted Avg Shares
|
2.10 | 38.79 | 35.93 | 35.82 | - |
|
Comprehensive Income
|
- | - | - | - | - |